PT 141 (Bremelanotide) | 10mg

What is PT141 (Bremelanotide)?

PT 141 is a peptide developed by Palatin Technologies that acts as an agonist of the melanocortin MC1 receptor, used for the treatment of various sexual dysfunctions and other health issues.

Bremelanotide is the synthetic analog of the melanocyte-stimulating hormone (α-MSH), which stimulates melanin production in the skin. PT141 was created as a remedy for sexual dysfunction, and is also used for the treatment of other medical problems.

PT 141 acts as a stimulant of melanocyte receptors and xanthine receptors. This helps to increase libido and sexual desire in both men and women. This peptide helps to improve erectile function in men and assists in the treatment of various types of sexual dysfunctions in women.

Research continues on Bremelanotide PT 141 for its positive impact on depression, mental health, chronic pain, hormonal imbalance, and other health issues. 

What are the benefits of PT 141 peptide (Bremelanotide)?

Bremelanotide PT 141 is a peptide that supports sexual function in women and men. The application of PT 141 has the following benefits:

• PT 141 improves libido and increases sexual desire in both men and women.
• PT141 improves erectile function in men and helps improve circulation in the genital organs.
• The PT141 peptide enhances sexual sensations and increases the achievement of a more pleasurable orgasm.
• PT 141 does not affect mental health and does not cause a feeling of euphoria.
• The PT141 peptide is used in the treatment of various sexual dysfunctions in women and men, as an alternative to other pharmaceutical products.
• PT141 leads to improved self-esteem and confidence during sexual contact.
• It does not cause adverse effects on the body or psyche of the user.
• It is useful in female sexual dysfunction, improving the experience and sexual desire.
• PT 141 has a beneficial effect on post-traumatic stress disorder, reducing the feeling of fear, anxiety, and worry.
• The PT141 peptide acts quickly, and the effect of its intake is observed within hours.

Clinical trials of the PT 141 peptide and their results:

PT 141 is used to support sexual function in men and women. Numerous clinical trials have demonstrated its positive effect in treating sexual dysfunctions.

In a clinical trial conducted in 2000 by Dr. Hyla Cass, women suffering from hypersexuality disorder participated. The participants were divided into two groups, where the first was treated with PT 141 and the second with a placebo. The results showed that in the women who received the PT 141 peptide, a higher level of sexual desire and greater satisfaction with sexual activity were observed.

In 2004, another clinical study was conducted involving 20 men suffering from erectile dysfunction. With the application of PT 141, a significantly higher level of sexual stimulation, a more durable erection, and an overall improvement in sexual function were observed.

In 2010, a third study on the impact of PT141 was published in the "Journal of Sexual Medicine". In this study, 327 women suffering from hypersexuality disorder participated. With the application of PT-141 in the participants, an improvement in sexual satisfaction, desire, and activity was found.

Correct administration and dosage of PT141:

The dose of the PT141 peptide may vary according to the individual needs of the patient.

Normally, the initial dose is 400 mcg. to 700 mcg. of PT 141. Expected effect from 1 to 6 hours. Administration schedule: 8 subcutaneous units up to 7 hours before sexual contact preferably at night and another 5 units in the morning. Expected effect: in the following 30 hours. Second administration schedule: 10-12 units several hours before sexual contact.

A pen contains 200 units per 50 micrograms.

Examples of calculated units from the PT-141 pen (10mg) corresponding to micrograms:

1 unit = 50mcg; 5 units = 250mcg; 10 units = 500mcg; 12 units = 600mcg; 15 units = 750mcg.

What other peptides can PT 141 be combined with?

PT-141 (Bremelanotide) is a peptide used to increase sexual desire and improve sexual function in men and women. When combined with other peptides, it can enhance or extend its effect. Here are some peptides with which PT-141 can be combined:

• Melanotan II - Combining PT 141 with Melanotan II is a popular combination to improve sexual health. This combination can have a synergistic effect, increasing sexual desire and improving erectile function in men and libido in women.
• Ipamorelin - This peptide is known for its ability to stimulate the release of growth hormone and can be combined with PT 141 to enhance sexual function and increase energy and endurance.

Here we have listed only a small part of the peptides that can be combined.

Possible side effects of PT 141:

PT 141 is a pharmaceutical product that has a positive effect on sexual dysfunctions in both men and women. Like any medication, its use can also cause some side effects. These are related to headaches, nausea, skin irritations, and increased blood pressure.

These side effects are mild and generally disappear within a few days. Consulting a specialist upon the appearance of any of these symptoms is advisable.

It is mandatory to follow the prescribed dosage and application instructions from a specialist to avoid more serious side effects.